参与观察性研究的遗传性视网膜疾病患者报告的经验测量。

IF 2.6 3区 医学 Q2 OPHTHALMOLOGY Translational Vision Science & Technology Pub Date : 2024-12-02 DOI:10.1167/tvst.13.12.9
Malena Daich Varela, Shaima Hashem, Dayyanah Sumodhee, Michel Michaelides
{"title":"参与观察性研究的遗传性视网膜疾病患者报告的经验测量。","authors":"Malena Daich Varela, Shaima Hashem, Dayyanah Sumodhee, Michel Michaelides","doi":"10.1167/tvst.13.12.9","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Inherited retinal disorders (IRD) are a complex group of conditions. By developing the first patient-reported experience measurement (PREM) questionnaire tailored for individuals with IRD participating in natural history studies, we gathered information on individuals' views of their experience while they are involved in research.</p><p><strong>Methods: </strong>Adults with IRD who (i) were enrolled in a natural history study taking place at Moorfields Eye Hospital (London, UK), (ii) had attended at least two study visits, (iii) the most recent one being less than two weeks before the questionnaire, and (iv) who were not involved in interventional research, were considered for participation.</p><p><strong>Results: </strong>Fifty individuals completed the PREM questionnaire at a mean age of 31.1 ± 11 years old and were diagnosed at a mean age of 14 ± 9.7 years old. Most individuals rated \"getting closer to receiving treatment' as their main motivation to enroll in the study, and their biggest influence was their own curiosity. Individuals were more satisfied with the care they received, and least satisfied with the efficiency of the visit. After validity and reliability assessments, the final PREM was created, with 27 questions and five sections, and Cronbach alpha coefficient between 0.316 and 0.756 in each section.</p><p><strong>Conclusions: </strong>The PREM instrument allowed us to assess the overall satisfaction of individuals with IRD involved in research, detect possible barriers to research participation, and ways of improving our care.</p><p><strong>Translational relevance: </strong>The final version can be included in future research and other sites worldwide, to maintain high quality standards.</p>","PeriodicalId":23322,"journal":{"name":"Translational Vision Science & Technology","volume":"13 12","pages":"9"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11629914/pdf/","citationCount":"0","resultStr":"{\"title\":\"Patient-Reported Experience Measurements From Individuals With Inherited Retinal Disorders Involved in Observational Research.\",\"authors\":\"Malena Daich Varela, Shaima Hashem, Dayyanah Sumodhee, Michel Michaelides\",\"doi\":\"10.1167/tvst.13.12.9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Inherited retinal disorders (IRD) are a complex group of conditions. By developing the first patient-reported experience measurement (PREM) questionnaire tailored for individuals with IRD participating in natural history studies, we gathered information on individuals' views of their experience while they are involved in research.</p><p><strong>Methods: </strong>Adults with IRD who (i) were enrolled in a natural history study taking place at Moorfields Eye Hospital (London, UK), (ii) had attended at least two study visits, (iii) the most recent one being less than two weeks before the questionnaire, and (iv) who were not involved in interventional research, were considered for participation.</p><p><strong>Results: </strong>Fifty individuals completed the PREM questionnaire at a mean age of 31.1 ± 11 years old and were diagnosed at a mean age of 14 ± 9.7 years old. Most individuals rated \\\"getting closer to receiving treatment' as their main motivation to enroll in the study, and their biggest influence was their own curiosity. Individuals were more satisfied with the care they received, and least satisfied with the efficiency of the visit. After validity and reliability assessments, the final PREM was created, with 27 questions and five sections, and Cronbach alpha coefficient between 0.316 and 0.756 in each section.</p><p><strong>Conclusions: </strong>The PREM instrument allowed us to assess the overall satisfaction of individuals with IRD involved in research, detect possible barriers to research participation, and ways of improving our care.</p><p><strong>Translational relevance: </strong>The final version can be included in future research and other sites worldwide, to maintain high quality standards.</p>\",\"PeriodicalId\":23322,\"journal\":{\"name\":\"Translational Vision Science & Technology\",\"volume\":\"13 12\",\"pages\":\"9\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-12-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11629914/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Vision Science & Technology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1167/tvst.13.12.9\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Vision Science & Technology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1167/tvst.13.12.9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:遗传性视网膜疾病(IRD)是一组复杂的疾病。通过开发首个为参与自然史研究的IRD患者量身定制的患者报告体验测量(PREM)问卷,我们收集了个人在参与研究时对其体验的看法的信息。方法:患有IRD的成年人(i)参加了在Moorfields眼科医院(伦敦,英国)进行的自然历史研究,(ii)参加了至少两次研究访问,(iii)最近一次是在问卷调查前不到两周,(iv)没有参与介入性研究,被考虑参加。结果:50例患者平均年龄(31.1±11岁)完成PREM问卷,平均年龄(14±9.7岁)确诊。大多数人认为“更接近接受治疗”是他们参加这项研究的主要动机,他们最大的影响是自己的好奇心。个人对他们得到的护理更满意,而对访问的效率最不满意。经过效度和信度评估,形成最终的PREM,共27题,5个部分,每个部分的Cronbach alpha系数在0.316 ~ 0.756之间。结论:PREM工具使我们能够评估参与研究的IRD患者的总体满意度,发现参与研究的可能障碍,以及改善我们护理的方法。翻译相关性:最终版本可以包含在未来的研究和世界各地的其他网站中,以保持高质量标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Patient-Reported Experience Measurements From Individuals With Inherited Retinal Disorders Involved in Observational Research.

Purpose: Inherited retinal disorders (IRD) are a complex group of conditions. By developing the first patient-reported experience measurement (PREM) questionnaire tailored for individuals with IRD participating in natural history studies, we gathered information on individuals' views of their experience while they are involved in research.

Methods: Adults with IRD who (i) were enrolled in a natural history study taking place at Moorfields Eye Hospital (London, UK), (ii) had attended at least two study visits, (iii) the most recent one being less than two weeks before the questionnaire, and (iv) who were not involved in interventional research, were considered for participation.

Results: Fifty individuals completed the PREM questionnaire at a mean age of 31.1 ± 11 years old and were diagnosed at a mean age of 14 ± 9.7 years old. Most individuals rated "getting closer to receiving treatment' as their main motivation to enroll in the study, and their biggest influence was their own curiosity. Individuals were more satisfied with the care they received, and least satisfied with the efficiency of the visit. After validity and reliability assessments, the final PREM was created, with 27 questions and five sections, and Cronbach alpha coefficient between 0.316 and 0.756 in each section.

Conclusions: The PREM instrument allowed us to assess the overall satisfaction of individuals with IRD involved in research, detect possible barriers to research participation, and ways of improving our care.

Translational relevance: The final version can be included in future research and other sites worldwide, to maintain high quality standards.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Translational Vision Science & Technology
Translational Vision Science & Technology Engineering-Biomedical Engineering
CiteScore
5.70
自引率
3.30%
发文量
346
审稿时长
25 weeks
期刊介绍: Translational Vision Science & Technology (TVST), an official journal of the Association for Research in Vision and Ophthalmology (ARVO), an international organization whose purpose is to advance research worldwide into understanding the visual system and preventing, treating and curing its disorders, is an online, open access, peer-reviewed journal emphasizing multidisciplinary research that bridges the gap between basic research and clinical care. A highly qualified and diverse group of Associate Editors and Editorial Board Members is led by Editor-in-Chief Marco Zarbin, MD, PhD, FARVO. The journal covers a broad spectrum of work, including but not limited to: Applications of stem cell technology for regenerative medicine, Development of new animal models of human diseases, Tissue bioengineering, Chemical engineering to improve virus-based gene delivery, Nanotechnology for drug delivery, Design and synthesis of artificial extracellular matrices, Development of a true microsurgical operating environment, Refining data analysis algorithms to improve in vivo imaging technology, Results of Phase 1 clinical trials, Reverse translational ("bedside to bench") research. TVST seeks manuscripts from scientists and clinicians with diverse backgrounds ranging from basic chemistry to ophthalmic surgery that will advance or change the way we understand and/or treat vision-threatening diseases. TVST encourages the use of color, multimedia, hyperlinks, program code and other digital enhancements.
期刊最新文献
Associations Between Diabetic Retinopathy and Frailty: Insights From the National Health and Nutrition Examination Survey and Mendelian Randomization. Effect of the Sugar Present in the Culture Medium on the Preservation of Human RPE Cell Suspensions. Advanced Artificial-Intelligence-Based Jiang Formula for Intraocular Lens Power in Congenital Ectopia Lentis. Detecting and Quantifying Glaucomatous Visual Function Loss With Continuous Visual Stimulus Tracking: A Case-Control Study. RetOCTNet: Deep Learning-Based Segmentation of OCT Images Following Retinal Ganglion Cell Injury.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1